151 related articles for article (PubMed ID: 27255379)
21. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
Ottóffy G; Horváth P; Muth L; Sólyom A; Garami M; Kovács G; Nyári T; Molnár D; Pauler G; Jankovics I
Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
[TBL] [Abstract][Full Text] [Related]
23. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
24. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.
Subbramanian RA; Basha S; Shata MT; Brady RC; Bernstein DI
Vaccine; 2010 Dec; 28(52):8258-67. PubMed ID: 21050903
[TBL] [Abstract][Full Text] [Related]
25. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
Cherukuri A; Servat E; Woo J
Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173
[TBL] [Abstract][Full Text] [Related]
26. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.
Jackson KJ; Liu Y; Roskin KM; Glanville J; Hoh RA; Seo K; Marshall EL; Gurley TC; Moody MA; Haynes BF; Walter EB; Liao HX; Albrecht RA; García-Sastre A; Chaparro-Riggers J; Rajpal A; Pons J; Simen BB; Hanczaruk B; Dekker CL; Laserson J; Koller D; Davis MM; Fire AZ; Boyd SD
Cell Host Microbe; 2014 Jul; 16(1):105-14. PubMed ID: 24981332
[TBL] [Abstract][Full Text] [Related]
27. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
28. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
[TBL] [Abstract][Full Text] [Related]
29. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients.
Cherif H; Höglund M; Pauksens K
Eur J Haematol; 2013 May; 90(5):413-9. PubMed ID: 23444982
[TBL] [Abstract][Full Text] [Related]
30. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
[TBL] [Abstract][Full Text] [Related]
32. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
33. Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine.
Chao DY; Cheng KF; Hsieh YH; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH;
Vaccine; 2011 Jan; 29(4):617-23. PubMed ID: 21095255
[TBL] [Abstract][Full Text] [Related]
34. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G
Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
Kositanont U; Assantachai P; Wasi C; Puthavathana P; Praditsuwan R
Viral Immunol; 2012 Dec; 25(6):471-6. PubMed ID: 23061793
[TBL] [Abstract][Full Text] [Related]
36. Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients.
Felldin M; Andersson B; Studahl M; Svennerholm B; Friman V
Transpl Int; 2014 Feb; 27(2):197-203. PubMed ID: 24289658
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.
Vajo Z; Tamas F; Sinka L; Jankovics I
Lancet; 2010 Jan; 375(9708):49-55. PubMed ID: 20018367
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
[TBL] [Abstract][Full Text] [Related]
39. Influenza Virus-Specific Human Antibody Repertoire Studies.
Crowe JE
J Immunol; 2019 Jan; 202(2):368-373. PubMed ID: 30617118
[TBL] [Abstract][Full Text] [Related]
40. Random yet deterministic: convergent immunoglobulin responses to influenza.
Martins AJ; Tsang JS
Trends Microbiol; 2014 Sep; 22(9):488-9. PubMed ID: 25179798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
